Cugrastomig

A4DAB077 | Phase-I/II
LAG3/CD223;PDCD1/CD279/PD1
G1;non-canonical / None
Akeso Biopharma Kangfang Huike (Shanghai) Biology Co
Phase-I/II
Bispecific Mixed mAb and scFv
AK 129 AK-129 AK129
—
IMGT PubChem (496143715) PubChem (520378124) Thera-SAbDab YAbS
Avg A4D Score
-0.6896
Score Range
-0.69 to -0.69
Structures
2
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB077_7um3_H_L 7um3 97% -0.691 6.5 4.0 -0.3085 -0.7361
A4DAB077_7um3_I_M 7um3 97% -0.6883 6.5 4.0 -0.3144 -0.7323